Quadrivalent adjuvanted subunit inactivated influenza vaccine (NPO Petrovax)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameQuadrivalent adjuvanted subunit inactivated influenza vaccine (NPO Petrovax)
Drug Alias NameGrippol quadrivalent (NPO Petrovax Pharm)
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanRespiratory Tract Infections +[4] 
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2018/07/01
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNpo Petrovax Pharm
China Registration ClassN/A

Develop Information

Active CompaniesNpo PetrovaxNpo Petrovax Pharm
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanRespiratory Tract Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A